Beranda › Kanker Prostat › Vermont › Burlington
Uji klinis Kanker Prostat di Burlington, VT
4 studi untuk Kanker Prostat mencari peserta di lokasi sekitar Burlington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Menerima pesertaFase 3
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Menerima pesertaFase 3
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer
Menerima pesertaFase 2
- University of Vermont Medical Center, Burlington
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Menerima pesertaFase 3
- University of Vermont Medical Center, Burlington
Uji klinis Kanker Prostat di kota lain
- New York City, NY103 studi
- Houston, TX76 studi
- Los Angeles, CA61 studi
- Boston, MA59 studi
- St. Louis, MO46 studi
- Chicago, IL45 studi
- San Francisco, CA45 studi
- Philadelphia, PA44 studi
- Baltimore, MD43 studi
- Nashville, TN43 studi
- Seattle, WA42 studi
- Washington, DC38 studi
Studi lain di Burlington
- Gagal Jantung8 studi
- Leukemia Mieloid Akut7 studi
- Kanker (semua jenis)6 studi
- PPOK5 studi
- Kanker Payudara5 studi
- Leukemia4 studi
- Penyakit Parkinson4 studi
- Kanker Paru4 studi
- Penyakit Kardiovaskular4 studi
- Fibrosis Kistik4 studi
- Kanker Paru Non-Sel Kecil4 studi
- Kanker Metastatik4 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.